as 05-09-2025 4:00pm EST
Founded: | 1954 | Country: | United States |
Employees: | N/A | City: | GREENFIELD |
Market Cap: | N/A | IPO Year: | 2018 |
Target Price: | $15.00 | AVG Volume (30 days): | 6.2M |
Analyst Decision: | Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.75 | EPS Growth: | N/A |
52 Week Low/High: | $8.02 - $18.80 | Next Earning Date: | 05-07-2025 |
Revenue: | $4,427,000,000 | Revenue Growth: | 1.42% |
Revenue Growth (this year): | 3% | Revenue Growth (next year): | 4.29% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Kurzius Lawrence Erik | ELAN | Director | Mar 7 '25 | Buy | $10.55 | 20,000 | $211,000.00 | 111,459 | |
HOOVER R DAVID | ELAN | Director | Mar 5 '25 | Buy | $10.90 | 25,000 | $272,557.50 | 210,000 |
ELAN Breaking Stock News: Dive into ELAN Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
Simply Wall St.
a day ago
GuruFocus.com
2 days ago
Insider Monkey
2 days ago
MT Newswires
2 days ago
StockStory
2 days ago
Zacks
2 days ago
Zacks
2 days ago
The information presented on this page, "ELAN Elanco Animal Health Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.